These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5424370)

  • 1. Partial purification and properties of urokinase inhibitor from human placenta.
    Kawano T; Morimoto K; Uemura Y
    J Biochem; 1970 Mar; 67(3):333-42. PubMed ID: 5424370
    [No Abstract]   [Full Text] [Related]  

  • 2. Urokinase inhibitor in human placenta.
    Kawano T; Morimoto K; Uemura Y
    Nature; 1968 Jan; 217(5125):253-4. PubMed ID: 5639129
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial purification of human placental 15-hydroxy-prostaglandin dehydrogenase: kinetic properties.
    Schlegel W; Demers LM; Hildebrandt-Stark HE; Behrman HR; Greep RO
    Prostaglandins; 1974 Mar; 5(5):417-33. PubMed ID: 4822191
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification of rabbit kidney cytokinase and a comparison of its properties with human urokinase.
    Ali SY; Evans L
    Biochem J; 1968 Mar; 107(2):293-303. PubMed ID: 5641883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of streptokinase and human plasminogen. IV. Further gel electrophoretic studies on the combination of streptokinase with human plasminogen or human plasmin.
    De Renzo EC; Boggiano E; Barg WF; Buck FF
    J Biol Chem; 1967 May; 242(10):2428-34. PubMed ID: 4226006
    [No Abstract]   [Full Text] [Related]  

  • 6. Separation and characterization of two fibrinolytic inhibitors from human placenta.
    Uszynski M; Abildgaard U
    Thromb Diath Haemorrh; 1971 Jun; 25(3):580-9. PubMed ID: 4998018
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifibrinolytic activity in middle ear effusion.
    Hamaguchi Y; Sakakura Y; Ukai K; Ohi M; Miyoshi Y
    ORL J Otorhinolaryngol Relat Spec; 1984; 46(5):235-41. PubMed ID: 6237294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some properties of the tissue plasminogen activator from the pig heart.
    Hijikata A; Fujimoto K; Kitaguchi H; Okamoto S
    Thromb Res; 1974 Jun; 4(6):731-40. PubMed ID: 4844057
    [No Abstract]   [Full Text] [Related]  

  • 9. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elastase and trypsin inhibitors of human skin and serum. Partial purification and characterization.
    Junnila SK; Jansén CT; Hopsu-Havu VK
    Acta Derm Venereol; 1971; 51(4):251-6. PubMed ID: 4105770
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of alpha-1-antitrypsin on plasmin, urokinase and Hageman factor cofactor.
    Crawford GP; Ogston D
    Biochim Biophys Acta; 1974 Jun; 354(1):107-13. PubMed ID: 4276997
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasminogen activator and urokinase inhibitor in myometrium, placenta, and amniotic fluid.
    Uszyński M; Uszyński-Folejewska R
    Am J Obstet Gynecol; 1969 Dec; 105(7):1041-3. PubMed ID: 5352583
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunochemical distinction between antiplasmin and alpha-antitrypsin.
    Collen D; De Cock ; Verstraete M
    Thromb Res; 1975 Jul; 7(1):245-9. PubMed ID: 1080301
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation of IgA and of a fast subfraction of IgG from human placenta extract.
    Byszewska E; Zakrzewski K
    Acta Biochim Pol; 1974; 21(3):365-75. PubMed ID: 4216218
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isolation and purification of placental coagulation inhibitor].
    Shidara Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2583-92. PubMed ID: 6520478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of streptokinase-induced activator].
    Heimburger N; Schwick HG
    Arzneimittelforschung; 1971 Oct; 21(10):1439-43. PubMed ID: 4257977
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasminogen activator formed by reaction of streptokinase with human plasminogen.
    Ts'ao CH; Kline DL
    J Appl Physiol; 1969 May; 26(5):634-9. PubMed ID: 4238461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isolation and purification of the pancreatic secretory trypsin inhibitor of the cat].
    Tschesche H; Kupfer S
    Hoppe Seylers Z Physiol Chem; 1971 May; 352(5):764-6. PubMed ID: 5579983
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.
    Berg W
    Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608
    [No Abstract]   [Full Text] [Related]  

  • 20. Trypsin inhibitor from field beans (Dolichos lablab). Isolation, purification and properties of a trypsin inhibitor from field beans.
    Banerji AP; Sohonie K
    Enzymologia; 1969; 36(3):137-52. PubMed ID: 5777425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.